Arkema S.A. (EPA:AKE)
France · Delayed Price · Currency is EUR | Market Cap | 4.61B -8.1% |
| Revenue (ttm) | 8.87B -7.5% |
| Net Income | 17.00M -87.4% |
| EPS | 0.23 -94.1% |
| Shares Out | 75.67M |
| PE Ratio | 270.48 |
| Forward PE | 12.39 |
| Dividend | 3.60 (5.91%) |
| Ex-Dividend Date | May 25, 2026 |
| Volume | 243,443 |
| Open | 60.90 |
| Previous Close | 60.90 |
| Day's Range | 60.10 - 61.90 |
| 52-Week Range | 48.30 - 67.05 |
| Beta | 0.96 |
| Analysts | Buy |
| Price Target | 63.88 (+6.03%) |
| Earnings Date | May 6, 2026 |
About Arkema
Arkema S.A., together with its subsidiaries, manufactures and sells specialty materials in Europe, the United States, Canada, Mexico, China, Hong Kong, Taiwan, and internationally. It operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The company provides solutions for construction, renovation of buildings, and DIY; high performance adhesives for durable goods, and adhesive solutions for packaging and non-woven; and supplies technologies used in building activities for businesses and ind... [Read more]
Financial Performance
In 2025, Arkema's revenue was 9.07 billion, a decrease of -4.99% compared to the previous year's 9.54 billion. Earnings were 39.00 million, a decrease of -88.46%.
Financial StatementsNews
Arkema downgraded to Underweight from Neutral at JPMorgan
JPMorgan downgraded Arkema (ARKAY) to Underweight from Neutral with a EUR 10 price target as part of a broader sector note on European Chemicals. Mid-term earnings and ROIC outlook remains…
Arkema Slides: FY 2026
Arkema has posted slides in relation to its FY 2026 quarterly earnings report, which was published on May 21, 2026.
Arkema downgraded to Reduce from Hold at Kepler Cheuvreux
Kepler Cheuvreux analyst Martin Roediger downgraded Arkema (ARKAY) to Reduce from Hold with a EUR 60 price target
Arkema Earnings Call Transcript: Q1 2026
Q1 2026 delivered stable volumes and strong Specialty Materials growth, offset by currency headwinds and weak U.S./Europe demand. EBITDA rose 14% sequentially but fell year-on-year; price increases and major projects are set to support Q2 and full-year guidance.
Arkema Earnings release: Q1 2026
Arkema released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
Arkema Slides: Q1 2026
Arkema has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.
Arkema downgraded to Hold from Buy at Berenberg
Berenberg analyst Sebastian Bray downgraded Arkema (ARKAY) to Hold from Buy with an unchanged price target of EUR 62. The firm cites valuation for the downgrade with the shares reaching…
Arkema upgraded to Market Perform from Underperform at Bernstein
Bernstein upgraded Arkema (ARKAY) to Market Perform from Underperform with a price target of EUR 64, up from EUR 54. The firm says the company has reached the end of…
Arkema price target raised to EUR 50 from EUR 49 at Deutsche Bank
Deutsche Bank analyst Virginie Boucher-Ferte raised the firm’s price target on Arkema (ARKAY) to EUR 50 from EUR 49 and keeps a Hold rating on the shares. Published first on…
Arkema price target raised to EUR 83 from EUR 78 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Arkema (ARKAY) to EUR 83 from EUR 78 and keeps an Overweight rating on the shares.
Arkema price target raised to EUR 62 from EUR 60 at Berenberg
Berenberg raised the firm’s price target on Arkema (ARKAY) to EUR 62 from EUR 60 and keeps a Buy rating on the shares.
Arkema downgraded to Hold from Buy at Kepler Cheuvreux
Kepler Cheuvreux downgraded Arkema (ARKAY) to Hold from Buy with a EUR 65 price target
Arkema Earnings Call Transcript: Q4 2025
2025 saw revenue and EBITDA decline amid weak demand in Europe and the U.S., but strong cash generation and cost savings exceeded targets. Outlook for 2026 is cautious, with slight EBITDA growth expected and continued focus on cost control and project ramp-up.
Arkema Annual report: Q4 2025
Arkema has published its Q4 2025 annual report on February 26, 2026.
Arkema Earnings release: Q4 2025
Arkema released its Q4 2025 earnings on February 26, 2026, summarizing the period's financial results.
Arkema Slides: Q4 2025
Arkema has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 26, 2026.
Arkema upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs upgraded Arkema (ARKAY) to Buy from Neutral with a price target of EUR 71, up from EUR 51. The firm adjusted seven ratings in the European chemicals group,…
Arkema price target lowered to EUR 50 from EUR 55 at JPMorgan
JPMorgan lowered the firm’s price target on Arkema (ARKAY) to EUR 50 from EUR 55 and keeps a Neutral rating on the shares.
Arkema price target lowered to EUR 70 from EUR 80 at Citi
Citi lowered the firm’s price target on Arkema (ARKAY) to EUR 70 from EUR 80 and keeps a Buy rating on the shares.
Arkema downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Virginie Boucher-Ferte downgraded Arkema (ARKAY) to Hold from Buy with a price target of EUR 49, down from EUR 65. The firm reduced estimates to reflect macro…
Arkema price target raised to EUR 60 from EUR 58 at Berenberg
Berenberg raised the firm’s price target on Arkema (ARKAY) to EUR 60 from EUR 58 and keeps a Buy rating on the shares.
Arkema downgraded to Underweight from Equal Weight at Barclays
Barclays downgraded Arkema (ARKAY) to Underweight from Equal Weight with a EUR 47 price target The firm has a negative view on the European chemicals and ingredients group. Barclays prefers…
Arkema Earnings Call Transcript: Q3 2025
Q3 2025 saw sales down 8.6% year-on-year amid weak U.S. and European demand, but strong growth in Asia and targeted markets like batteries and fluorospecialties. Cost savings and disciplined capital allocation supported cash flow, with 2025 EBITDA guidance set at €1.25–1.3 billion.
Arkema Earnings release: Q3 2025
Arkema released its Q3 2025 earnings on November 7, 2025, summarizing the period's financial results.